Abu Dhabi Introduces WINREVAIR: A Major Breakth...

By João L. Carapinha

January 7, 2025

The Department of Health – Abu Dhabi (DoH) has announced the introduction of WINREVAIR for Pulmonary Arterial Hypertension (PAH). Developed by MSD, this innovative treatment is a significant step forward for this severe condition in the Emirate. ...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.